Glycotek developing oral alternative to heparin
A drug development company, Glycotek, is establishing a laboratory at the Hershey Center for Applied Research (HCAR) in Hummelstown, Penn., to focus on a long sought after oral alternative to heparin to treat deep vein thrombosis and other thrombotic conditions, as well as cancer, according to Business Wire.